Tapewire

Nasdaq · USD

RANI

Rani Therapeutics Holdings, Inc.

Export transactions ↓
Tapewire entity
6642
SEC CIK
0001856725
Parsed reports
194

Last 12 months

Inside the activity.

2 purchase rows · 1 sale rows

Disclosed non-derivative P/S rows, by transaction month. Includes amendments and private transactions.
Monthly counts
MonthPurchasesSales
Nov 202500
Dec 202500
Jan 202600
Feb 202600
Mar 202601
Apr 202600
May 202600
Jun 202600
Jul 202620
Aug 202600
Sep 202600
Oct 202600

Latest available

Insider transactions

JSON API
Reset

Purchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”

The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.

Transaction dateOwner / reported roleActivity / securityShares / unitsReported priceReported valueDetails
December 16, 2024 Filed Dec 17, 2024 22:00 UTC Disposition to issuerStock Option (Right to Buy) · Derivative 18,875 Not disclosed Strike: $2.84 Not disclosed
Disclosure

SEC source: 0000950170-24-137323 · ownership.xml · derivative · entry 3

BUTEL JEAN LUC · CIK 0001260801 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 0

Underlying: Class A Common Stock · 18,875 shares

Expires 2031-07-28

F3 · price: On December 16, 2024, the exercise price of the stock options has been amended to increase the exercise price to $9.44 per share. There is no change to the expiration dates or the vesting schedule of the options.

F2 · derivative.exercise_date: The shares subject to the option vested as follows: 1/3rd of the shares subject to the option vested on April 20, 2022; and 1/36th of the shares subject to the option vested monthly over the following two years.

Read SEC document
December 16, 2024 Filed Dec 17, 2024 22:00 UTC GrantStock Option (Right to Buy) · Derivative 101,276 Not disclosed Strike: $4.11 Not disclosed
Disclosure

SEC source: 0000950170-24-137323 · ownership.xml · derivative · entry 2

BUTEL JEAN LUC · CIK 0001260801 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 101,276

Underlying: Class A Common Stock · 101,276 shares

Expires 2033-05-24

F1 · price: On December 16, 2024, the exercise price of the stock options has been amended to increase the exercise price to $4.11 per share. There is no change to the expiration dates or the vesting schedule of the options.

Read SEC document
December 16, 2024 Filed Dec 17, 2024 22:00 UTC Disposition to issuerStock Option (Right to Buy) · Derivative 101,276 Not disclosed Strike: $2.84 Not disclosed
Disclosure

SEC source: 0000950170-24-137323 · ownership.xml · derivative · entry 1

BUTEL JEAN LUC · CIK 0001260801 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 0

Underlying: Class A Common Stock · 101,276 shares

Expires 2033-05-24

F1 · price: On December 16, 2024, the exercise price of the stock options has been amended to increase the exercise price to $4.11 per share. There is no change to the expiration dates or the vesting schedule of the options.

Read SEC document
December 16, 2024 Filed Dec 17, 2024 22:00 UTC GrantStock Option (Right to Buy) · Derivative 15,423 Not disclosed Strike: $9.44 Not disclosed
Disclosure

SEC source: 0000950170-24-137321 · ownership.xml · derivative · entry 4

Ausiello Dennis A · CIK 0001381994 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 79,317

Underlying: Class A Common Stock · 15,423 shares

Expires 2031-07-28

F3 · price: On December 16, 2024, the exercise price of the stock options has been amended to increase the exercise price to $9.44 per share. There is no change to the expiration dates or the vesting schedule of the options.

F2 · derivative.exercise_date: The shares subject to the option vested as follows: 1/36th of the shares subject to the option vested monthly over three years from June 17, 2021.

Read SEC document
December 16, 2024 Filed Dec 17, 2024 22:00 UTC Disposition to issuerStock Option (Right to Buy) · Derivative 15,423 Not disclosed Strike: $2.84 Not disclosed
Disclosure

SEC source: 0000950170-24-137321 · ownership.xml · derivative · entry 3

Ausiello Dennis A · CIK 0001381994 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 0

Underlying: Class A Common Stock · 15,423 shares

Expires 2031-07-28

F3 · price: On December 16, 2024, the exercise price of the stock options has been amended to increase the exercise price to $9.44 per share. There is no change to the expiration dates or the vesting schedule of the options.

F2 · derivative.exercise_date: The shares subject to the option vested as follows: 1/36th of the shares subject to the option vested monthly over three years from June 17, 2021.

Read SEC document
December 16, 2024 Filed Dec 17, 2024 22:00 UTC GrantStock Option (Right to Buy) · Derivative 101,276 Not disclosed Strike: $4.11 Not disclosed
Disclosure

SEC source: 0000950170-24-137321 · ownership.xml · derivative · entry 2

Ausiello Dennis A · CIK 0001381994 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 101,276

Underlying: Class A Common Stock · 101,276 shares

Expires 2033-05-24

F1 · price: On December 16, 2024, the exercise price of the stock options has been amended to increase the exercise price to $4.11 per share. There is no change to the expiration dates or the vesting schedule of the options.

Read SEC document
December 16, 2024 Filed Dec 17, 2024 22:00 UTC Disposition to issuerStock Option (Right to Buy) · Derivative 101,276 Not disclosed Strike: $2.84 Not disclosed
Disclosure

SEC source: 0000950170-24-137321 · ownership.xml · derivative · entry 1

Ausiello Dennis A · CIK 0001381994 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 0

Underlying: Class A Common Stock · 101,276 shares

Expires 2033-05-24

F1 · price: On December 16, 2024, the exercise price of the stock options has been amended to increase the exercise price to $4.11 per share. There is no change to the expiration dates or the vesting schedule of the options.

Read SEC document
December 16, 2024 Filed Dec 17, 2024 17:00 UTC GrantStock Option (Right to Buy) · Derivative 15,423 Not disclosed Strike: $9.44 Not disclosed
Disclosure

SEC source: 0000950170-24-137313 · ownership.xml · derivative · entry 4

Nanavaty Maulik · CIK 0001529708 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 79,317

Underlying: Class A Common Stock · 15,423 shares

Expires 2031-07-28

F3 · price: On December 16, 2024, the exercise price of the stock options has been amended to increase the exercise price to $9.44 per share. There is no change to the expiration dates or the vesting schedule of the options.

F2 · derivative.exercise_date: The shares subject to the option vested as follows: 1/36th of the shares subject to the option vested monthly over three years from June 17, 2021.

Read SEC document
December 16, 2024 Filed Dec 17, 2024 17:00 UTC Disposition to issuerStock Option (Right to Buy) · Derivative 15,423 Not disclosed Strike: $2.84 Not disclosed
Disclosure

SEC source: 0000950170-24-137313 · ownership.xml · derivative · entry 3

Nanavaty Maulik · CIK 0001529708 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 0

Underlying: Class A Common Stock · 15,423 shares

Expires 2031-07-28

F3 · price: On December 16, 2024, the exercise price of the stock options has been amended to increase the exercise price to $9.44 per share. There is no change to the expiration dates or the vesting schedule of the options.

F2 · derivative.exercise_date: The shares subject to the option vested as follows: 1/36th of the shares subject to the option vested monthly over three years from June 17, 2021.

Read SEC document
December 16, 2024 Filed Dec 17, 2024 17:00 UTC GrantStock Option (Right to Buy) · Derivative 101,276 Not disclosed Strike: $4.11 Not disclosed
Disclosure

SEC source: 0000950170-24-137313 · ownership.xml · derivative · entry 2

Nanavaty Maulik · CIK 0001529708 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 101,276

Underlying: Class A Common Stock · 101,276 shares

Expires 2033-05-24

F1 · price: On December 16, 2024, the exercise price of the stock options has been amended to increase the exercise price to $4.11 per share. There is no change to the expiration dates or the vesting schedule of the options.

Read SEC document
December 16, 2024 Filed Dec 17, 2024 17:00 UTC Disposition to issuerStock Option (Right to Buy) · Derivative 101,276 Not disclosed Strike: $2.84 Not disclosed
Disclosure

SEC source: 0000950170-24-137313 · ownership.xml · derivative · entry 1

Nanavaty Maulik · CIK 0001529708 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 0

Underlying: Class A Common Stock · 101,276 shares

Expires 2033-05-24

F1 · price: On December 16, 2024, the exercise price of the stock options has been amended to increase the exercise price to $4.11 per share. There is no change to the expiration dates or the vesting schedule of the options.

Read SEC document
December 16, 2024 Filed Dec 17, 2024 22:00 UTC GrantStock Option (Right to Buy) · Derivative 17,708 Not disclosed Strike: $9.44 Not disclosed
Disclosure

SEC source: 0000950170-24-137318 · ownership.xml · derivative · entry 4

Rometty Lisa Ann · CIK 0001902958 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 49,037

Underlying: Class A Common Stock · 17,708 shares

Expires 2032-01-02

F3 · price: On December 16, 2024, the exercise price of the stock options has been amended to increase the exercise price to $17.00 per share. There is no change to the expiration dates or the vesting schedule of the options.

F2 · derivative.exercise_date: The shares subject to the option vest as follows: 1/3rd of the shares subject to the option vested on January 3, 2023; and 1/36th of the shares subject to the option vest monthly over the following two years.

Read SEC document
December 16, 2024 Filed Dec 17, 2024 22:00 UTC Disposition to issuerStock Option (Right to Buy) · Derivative 17,708 Not disclosed Strike: $2.84 Not disclosed
Disclosure

SEC source: 0000950170-24-137318 · ownership.xml · derivative · entry 3

Rometty Lisa Ann · CIK 0001902958 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 0

Underlying: Class A Common Stock · 17,708 shares

Expires 2032-01-02

F3 · price: On December 16, 2024, the exercise price of the stock options has been amended to increase the exercise price to $17.00 per share. There is no change to the expiration dates or the vesting schedule of the options.

F2 · derivative.exercise_date: The shares subject to the option vest as follows: 1/3rd of the shares subject to the option vested on January 3, 2023; and 1/36th of the shares subject to the option vest monthly over the following two years.

Read SEC document
December 16, 2024 Filed Dec 17, 2024 22:00 UTC GrantStock Option (Right to Buy) · Derivative 101,276 Not disclosed Strike: $4.11 Not disclosed
Disclosure

SEC source: 0000950170-24-137318 · ownership.xml · derivative · entry 2

Rometty Lisa Ann · CIK 0001902958 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 101,276

Underlying: Class A Common Stock · 101,276 shares

Expires 2033-05-24

F1 · price: On December 16, 2024, the exercise price of the stock options has been amended to increase the exercise price to $4.11 per share. There is no change to the expiration dates or the vesting schedule of the options.

Read SEC document
December 16, 2024 Filed Dec 17, 2024 22:00 UTC Disposition to issuerStock Option (Right to Buy) · Derivative 101,276 Not disclosed Strike: $2.84 Not disclosed
Disclosure

SEC source: 0000950170-24-137318 · ownership.xml · derivative · entry 1

Rometty Lisa Ann · CIK 0001902958 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 0

Underlying: Class A Common Stock · 101,276 shares

Expires 2033-05-24

F1 · price: On December 16, 2024, the exercise price of the stock options has been amended to increase the exercise price to $4.11 per share. There is no change to the expiration dates or the vesting schedule of the options.

Read SEC document
December 13, 2024 Filed Dec 16, 2024 23:00 UTC
McKinley KateChief Business Officer
PurchaseClass A Common Stock 17,960 $1.67 $29,993.20
Disclosure

SEC source: 0000950170-24-136787 · ownership.xml · nonDerivative · entry 1

McKinley Kate · CIK 0001979211 · Chief Business Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 17,960

Read SEC document
December 09, 2024 Filed Dec 10, 2024 18:12 UTC
Imran TalatDirector · Chief Executive Officer
PurchaseClass A Common Stock 10,296 $1.94 $19,974.24
Disclosure

SEC source: 0000950170-24-134828 · ownership.xml · nonDerivative · entry 1

Imran Talat · CIK 0001869579 · Director · Chief Executive Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 494,751

F1 · balance_after: Includes 12,343 shares held by VH Moll, L.P. The Reporting Person disclaims beneficial ownership of these securities except to the extent of his pecuniary interest therein.

Read SEC document
October 15, 2024 Filed Oct 17, 2024 16:30 UTC SaleClass A Common Stock 523,738 $3.26 $1,705,395.68
Disclosure

SEC source: 0001104659-24-109543 · tm2426414-2_4seq1.xml · nonDerivative · entry 2

South Cone Investments Limited Partnership · CIK 0001876412 · 10% owner

South Lake One LLC · CIK 0001794292 · 10% owner

Joint disclosure: these amounts are not allocated separately to each reporting owner.

10b5-1 filing: No plan indicated

Ownership: Indirect · Shares indirectly held through South Lake One LLC

Disclosed balance after: 8,302,194

F3 · kind: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $3.105 to $3.395, inclusive. The reporting persons undertake to provide to Rani, any security holder of Rani, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the range set forth in this footnote.

F3 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $3.105 to $3.395, inclusive. The reporting persons undertake to provide to Rani, any security holder of Rani, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the range set forth in this footnote.

F2 · ownership.nature: South Cone Investments Limited Partnership directly owns 100% of the issued and outstanding membership interest of South Lake One LLC.

Read SEC document
October 15, 2024 Filed Oct 17, 2024 16:30 UTC SaleClass A Common Stock 3,305,622 $2.55 $8,436,277.91
Disclosure

SEC source: 0001104659-24-109543 · tm2426414-2_4seq1.xml · nonDerivative · entry 1

South Cone Investments Limited Partnership · CIK 0001876412 · 10% owner

South Lake One LLC · CIK 0001794292 · 10% owner

Joint disclosure: these amounts are not allocated separately to each reporting owner.

10b5-1 filing: No plan indicated

Ownership: Indirect · Shares indirectly held through South Lake One LLC

Disclosed balance after: 8,825,932

F1 · kind: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $2.10 to $3.10, inclusive. The reporting persons undertake to provide to Rani Therapeutics Holdings, Inc. ("Rani"), any security holder of Rani, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the range set forth in this footnote.

F1 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $2.10 to $3.10, inclusive. The reporting persons undertake to provide to Rani Therapeutics Holdings, Inc. ("Rani"), any security holder of Rani, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the range set forth in this footnote.

F2 · ownership.nature: South Cone Investments Limited Partnership directly owns 100% of the issued and outstanding membership interest of South Lake One LLC.

Read SEC document
May 29, 2024 Filed May 30, 2024 20:48 UTC
IMRAN MIR ADirector
GrantStock Option (Right to Buy) · Derivative 50,000 $0.00 Strike: $5.00 $0.00
Disclosure

SEC source: 0000950170-24-066722 · ownership.xml · derivative · entry 1

IMRAN MIR A · CIK 0001031686 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 50,000

Underlying: Class A Common Stock · 50,000 shares

Expires 2034-05-28

F1 · derivative.exercise_date: The shares subject to the option vest in full on the first anniversary of the date of grant, subject to the recipient's Continuous Service (as defined in the Company's 2021 Equity Incentive Plan) through such vesting date; provided that, if earlier, the shares subject to the option will vest in full upon the occurrence of either of the following events: the Company's next annual stockholder meeting or a Change in Control (as defined in the Company's 2021 Equity Incentive Plan).

Read SEC document
May 29, 2024 Filed May 30, 2024 16:10 UTC GrantStock Option (Right to Buy) · Derivative 50,000 $0.00 Strike: $5.00 $0.00
Disclosure

SEC source: 0000950170-24-066580 · ownership.xml · derivative · entry 1

DEBUONO LAUREEN · CIK 0001034447 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 50,000

Underlying: Class A Common Stock · 50,000 shares

Expires 2034-05-28

F1 · derivative.exercise_date: The shares subject to the option vest in full on the first anniversary of the date of grant, subject to the recipient's Continuous Service (as defined in the Company's 2021 Equity Incentive Plan) through such vesting date; provided that, if earlier, the shares subject to the option will vest in full upon the occurrence of either of the following events: the Company's next annual stockholder meeting or a Change in Control (as defined in the Company's 2021 Equity Incentive Plan).

Read SEC document
May 29, 2024 Filed May 30, 2024 16:10 UTC GrantStock Option (Right to Buy) · Derivative 50,000 $0.00 Strike: $5.00 $0.00
Disclosure

SEC source: 0000950170-24-066582 · ownership.xml · derivative · entry 1

Farquharson Andrew · CIK 0001865699 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 50,000

Underlying: Class A Common Stock · 50,000 shares

Expires 2034-05-28

F1 · derivative.exercise_date: The shares subject to the option vest in full on the first anniversary of the date of grant, subject to the recipient's Continuous Service (as defined in the Company's 2021 Equity Incentive Plan) through such vesting date; provided that, if earlier, the shares subject to the option will vest in full upon the occurrence of either of the following events: the Company's next annual stockholder meeting or a Change in Control (as defined in the Company's 2021 Equity Incentive Plan).

Read SEC document
May 29, 2024 Filed May 30, 2024 20:10 UTC GrantStock Option (Right to Buy) · Derivative 50,000 $0.00 Strike: $5.00 $0.00
Disclosure

SEC source: 0000950170-24-066578 · ownership.xml · derivative · entry 1

BUTEL JEAN LUC · CIK 0001260801 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 50,000

Underlying: Class A Common Stock · 50,000 shares

Expires 2034-05-28

F1 · derivative.exercise_date: The shares subject to the option vest in full on the first anniversary of the date of grant, subject to the recipient's Continuous Service (as defined in the Company's 2021 Equity Incentive Plan) through such vesting date; provided that, if earlier, the shares subject to the option will vest in full upon the occurrence of either of the following events: the Company's next annual stockholder meeting or a Change in Control (as defined in the Company's 2021 Equity Incentive Plan).

Read SEC document
May 29, 2024 Filed May 30, 2024 20:10 UTC GrantStock Option (Right to Buy) · Derivative 50,000 $0.00 Strike: $5.00 $0.00
Disclosure

SEC source: 0000950170-24-066586 · ownership.xml · derivative · entry 1

Ausiello Dennis A · CIK 0001381994 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 50,000

Underlying: Class A Common Stock · 50,000 shares

Expires 2034-05-28

F1 · derivative.exercise_date: The shares subject to the option vest in full on the first anniversary of the date of grant, subject to the recipient's Continuous Service (as defined in the Company's 2021 Equity Incentive Plan) through such vesting date; provided that, if earlier, the shares subject to the option will vest in full upon the occurrence of either of the following events: the Company's next annual stockholder meeting or a Change in Control (as defined in the Company's 2021 Equity Incentive Plan).

Read SEC document
May 29, 2024 Filed May 30, 2024 16:10 UTC GrantStock Option (Right to Buy) · Derivative 50,000 $0.00 Strike: $5.00 $0.00
Disclosure

SEC source: 0000950170-24-066581 · ownership.xml · derivative · entry 1

Nanavaty Maulik · CIK 0001529708 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 50,000

Underlying: Class A Common Stock · 50,000 shares

Expires 2034-05-28

F1 · derivative.exercise_date: The shares subject to the option vest in full on the first anniversary of the date of grant, subject to the recipient's Continuous Service (as defined in the Company's 2021 Equity Incentive Plan) through such vesting date; provided that, if earlier, the shares subject to the option will vest in full upon the occurrence of either of the following events: the Company's next annual stockholder meeting or a Change in Control (as defined in the Company's 2021 Equity Incentive Plan).

Read SEC document
May 29, 2024 Filed May 30, 2024 20:10 UTC GrantStock Option (Right to Buy) · Derivative 50,000 $0.00 Strike: $5.00 $0.00
Disclosure

SEC source: 0000950170-24-066579 · ownership.xml · derivative · entry 1

Rometty Lisa Ann · CIK 0001902958 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 50,000

Underlying: Class A Common Stock · 50,000 shares

Expires 2034-05-28

F1 · derivative.exercise_date: The shares subject to the option vest in full on the first anniversary of the date of grant, subject to the recipient's Continuous Service (as defined in the Company's 2021 Equity Incentive Plan) through such vesting date; provided that, if earlier, the shares subject to the option will vest in full upon the occurrence of either of the following events: the Company's next annual stockholder meeting or a Change in Control (as defined in the Company's 2021 Equity Incentive Plan).

Read SEC document
March 21, 2024 Filed Mar 22, 2024 21:00 UTC
Hashim MirChief Scientific Officer
GrantStock Option (Right to Buy) · Derivative 323,500 $0.00 Strike: $3.60 $0.00
Disclosure

SEC source: 0000950170-24-035571 · ownership.xml · derivative · entry 1

Hashim Mir · CIK 0001875891 · Chief Scientific Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 323,500

Underlying: Class A Common Stock · 323,500 shares

Expires 2034-03-20

F1 · derivative.exercise_date: The shares subject to the option vest as follows: 1/48th of the shares subject to the option vest monthly over four years from March 21, 2024.

Read SEC document
March 21, 2024 Filed Mar 23, 2024 01:00 UTC
Imran TalatDirector · Chief Executive Officer
GrantStock Option (Right to Buy) · Derivative 1,085,000 $0.00 Strike: $3.60 $0.00
Disclosure

SEC source: 0000950170-24-035573 · ownership.xml · derivative · entry 1

Imran Talat · CIK 0001869579 · Director · Chief Executive Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 1,085,000

Underlying: Class A Common Stock · 1,085,000 shares

Expires 2034-03-20

F1 · derivative.exercise_date: The shares subject to the option vest as follows: 1/48th of the shares subject to the option vest monthly over four years from March 21, 2024.

Read SEC document
March 21, 2024 Filed Mar 22, 2024 21:00 UTC
Sanford Svai SChief Financial Officer
GrantStock Option (Right to Buy) · Derivative 323,500 $0.00 Strike: $3.60 $0.00
Disclosure

SEC source: 0000950170-24-035570 · ownership.xml · derivative · entry 1

Sanford Svai S · CIK 0001591411 · Chief Financial Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 323,500

Underlying: Class A Common Stock · 323,500 shares

Expires 2034-03-20

F1 · derivative.exercise_date: The shares subject to the option vest as follows: 1/48th of the shares subject to the option vest monthly over four years from March 21, 2024.

Read SEC document
March 21, 2024 Filed Mar 23, 2024 01:25 UTC
McKinley KateChief Business Officer
GrantStock Option (Right to Buy) · Derivative 323,500 $0.00 Strike: $3.60 $0.00
Disclosure

SEC source: 0000950170-24-035576 · ownership.xml · derivative · entry 1

McKinley Kate · CIK 0001979211 · Chief Business Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 323,500

Underlying: Class A Common Stock · 323,500 shares

Expires 2034-03-20

F1 · derivative.exercise_date: The shares subject to the option vest as follows: 1/48th of the shares subject to the option vest monthly over four years from March 21, 2024.

Read SEC document
March 21, 2024 Filed Mar 23, 2024 01:00 UTC
Groen EricGeneral Counsel
GrantStock Option (Right to Buy) · Derivative 323,500 $0.00 Strike: $3.60 $0.00
Disclosure

SEC source: 0000950170-24-035572 · ownership.xml · derivative · entry 1

Groen Eric · CIK 0001918630 · General Counsel

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 323,500

Underlying: Class A Common Stock · 323,500 shares

Expires 2034-03-20

F1 · derivative.exercise_date: The shares subject to the option vest as follows: 1/48th of the shares subject to the option vest monthly over four years from March 21, 2024.

Read SEC document
December 16, 2023 Filed Dec 19, 2023 21:05 UTC
IMRAN MIR ADirector
GrantStock Option (Right to Buy) · Derivative 101,276 Not disclosed Strike: $2.84 Not disclosed
Disclosure

SEC source: 0000950170-23-071465 · ownership.xml · derivative · entry 2

IMRAN MIR A · CIK 0001031686 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 101,276

Underlying: Class A Common Stock · 101,276 shares

Expires 2033-05-24

F2 · price: The transactions reported herein reflect a one-time stock option repricing (the "Option Repricing") effective on December 16, 2023 (the "Repricing Date"). Pursuant to the Option Repricing, the exercise price of the repriced options has been amended to reduce the exercise price to $2.84 per share, the closing price of the Issuer's Common Stock on the Repricing Date. There is no change to the expiration dates or the vesting schedule of the repriced options.

F1 · derivative.exercise_date: The shares subject to the option vest in full on May 25, 2024, subject to the recipient's Continuous Service (as defined in the Issuer's 2021 Equity Incentive Plan) through such vesting date; provided that, if earlier, the shares subject to the option will vest in full upon the occurrence of either of the following events: the Issuer's next annual stockholder meeting or a Change in Control (as defined in the 2021 Equity Incentive Plan).

Read SEC document
December 16, 2023 Filed Dec 19, 2023 21:05 UTC
IMRAN MIR ADirector
Disposition to issuerStock Option (Right to Buy) · Derivative 101,276 Not disclosed Strike: $4.11 Not disclosed
Disclosure

SEC source: 0000950170-23-071465 · ownership.xml · derivative · entry 1

IMRAN MIR A · CIK 0001031686 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 0

Underlying: Class A Common Stock · 101,276 shares

Expires 2033-05-24

F2 · price: The transactions reported herein reflect a one-time stock option repricing (the "Option Repricing") effective on December 16, 2023 (the "Repricing Date"). Pursuant to the Option Repricing, the exercise price of the repriced options has been amended to reduce the exercise price to $2.84 per share, the closing price of the Issuer's Common Stock on the Repricing Date. There is no change to the expiration dates or the vesting schedule of the repriced options.

F1 · derivative.exercise_date: The shares subject to the option vest in full on May 25, 2024, subject to the recipient's Continuous Service (as defined in the Issuer's 2021 Equity Incentive Plan) through such vesting date; provided that, if earlier, the shares subject to the option will vest in full upon the occurrence of either of the following events: the Issuer's next annual stockholder meeting or a Change in Control (as defined in the 2021 Equity Incentive Plan).

Read SEC document
December 16, 2023 Filed Dec 19, 2023 16:05 UTC GrantStock Option (Right to Buy) · Derivative 18,875 Not disclosed Strike: $2.84 Not disclosed
Disclosure

SEC source: 0000950170-23-071470 · ownership.xml · derivative · entry 4

DEBUONO LAUREEN · CIK 0001034447 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 18,875

Underlying: Class A Common Stock · 18,875 shares

Expires 2031-07-28

F2 · price: The transactions reported herein reflect a one-time stock option repricing (the "Option Repricing") effective on December 16, 2023 (the "Repricing Date"). Pursuant to the Option Repricing, the exercise price of the repriced options has been amended to reduce the exercise price to $2.84 per share, the closing price of the Issuer's Common Stock on the Repricing Date. There is no change to the expiration dates or the vesting schedule of the repriced options.

F4 · derivative.exercise_date: The shares subject to the option vest as follows: 1/3rd of the shares subject to the option vest on April 20, 2022; and 1/36th of the shares subject to the option vest monthly over the following two years.

Read SEC document
December 16, 2023 Filed Dec 19, 2023 16:05 UTC Disposition to issuerStock Option (Right to Buy) · Derivative 18,875 Not disclosed Strike: $9.44 Not disclosed
Disclosure

SEC source: 0000950170-23-071470 · ownership.xml · derivative · entry 3

DEBUONO LAUREEN · CIK 0001034447 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 117,021

Underlying: Class A Common Stock · 18,875 shares

Expires 2031-07-28

F2 · price: The transactions reported herein reflect a one-time stock option repricing (the "Option Repricing") effective on December 16, 2023 (the "Repricing Date"). Pursuant to the Option Repricing, the exercise price of the repriced options has been amended to reduce the exercise price to $2.84 per share, the closing price of the Issuer's Common Stock on the Repricing Date. There is no change to the expiration dates or the vesting schedule of the repriced options.

F3 · derivative.exercise_date: The remaining shares subject to the option are fully vested and exercisable as of the Repricing Date.

F4 · derivative.exercise_date: The shares subject to the option vest as follows: 1/3rd of the shares subject to the option vest on April 20, 2022; and 1/36th of the shares subject to the option vest monthly over the following two years.

F3 · balance_after: The remaining shares subject to the option are fully vested and exercisable as of the Repricing Date.

Read SEC document
December 16, 2023 Filed Dec 19, 2023 16:05 UTC GrantStock Option (Right to Buy) · Derivative 101,276 Not disclosed Strike: $2.84 Not disclosed
Disclosure

SEC source: 0000950170-23-071470 · ownership.xml · derivative · entry 2

DEBUONO LAUREEN · CIK 0001034447 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 101,276

Underlying: Class A Common Stock · 101,276 shares

Expires 2033-05-24

F2 · price: The transactions reported herein reflect a one-time stock option repricing (the "Option Repricing") effective on December 16, 2023 (the "Repricing Date"). Pursuant to the Option Repricing, the exercise price of the repriced options has been amended to reduce the exercise price to $2.84 per share, the closing price of the Issuer's Common Stock on the Repricing Date. There is no change to the expiration dates or the vesting schedule of the repriced options.

F1 · derivative.exercise_date: The shares subject to the option vest in full on May 25, 2024, subject to the recipient's Continuous Service (as defined in the Issuer's 2021 Equity Incentive Plan) through such vesting date; provided that, if earlier, the shares subject to the option will vest in full upon the occurrence of either of the following events: the Issuer's next annual stockholder meeting or a Change in Control (as defined in the 2021 Equity Incentive Plan).

Read SEC document
December 16, 2023 Filed Dec 19, 2023 16:05 UTC Disposition to issuerStock Option (Right to Buy) · Derivative 101,276 Not disclosed Strike: $4.11 Not disclosed
Disclosure

SEC source: 0000950170-23-071470 · ownership.xml · derivative · entry 1

DEBUONO LAUREEN · CIK 0001034447 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 0

Underlying: Class A Common Stock · 101,276 shares

Expires 2033-05-24

F2 · price: The transactions reported herein reflect a one-time stock option repricing (the "Option Repricing") effective on December 16, 2023 (the "Repricing Date"). Pursuant to the Option Repricing, the exercise price of the repriced options has been amended to reduce the exercise price to $2.84 per share, the closing price of the Issuer's Common Stock on the Repricing Date. There is no change to the expiration dates or the vesting schedule of the repriced options.

F1 · derivative.exercise_date: The shares subject to the option vest in full on May 25, 2024, subject to the recipient's Continuous Service (as defined in the Issuer's 2021 Equity Incentive Plan) through such vesting date; provided that, if earlier, the shares subject to the option will vest in full upon the occurrence of either of the following events: the Issuer's next annual stockholder meeting or a Change in Control (as defined in the 2021 Equity Incentive Plan).

Read SEC document
December 16, 2023 Filed Dec 19, 2023 16:05 UTC
Hashim MirChief Scientific Officer
GrantStock Option (Right to Buy) · Derivative 83,724 Not disclosed Strike: $2.84 Not disclosed
Disclosure

SEC source: 0000950170-23-071473 · ownership.xml · derivative · entry 6

Hashim Mir · CIK 0001875891 · Chief Scientific Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 83,724

Underlying: Class A Common Stock · 83,724 shares

Expires 2031-07-28

F3 · price: The transactions reported herein reflect a one-time stock option repricing (the "Option Repricing") effective on December 16, 2023 (the "Repricing Date"). Pursuant to the Option Repricing, the exercise price of the repriced options has been amended to reduce the exercise price to $2.84 per share, the closing price of the Issuer's Common Stock on the Repricing Date. There is no change to the expiration dates or the vesting schedule of the repriced options.

F5 · derivative.exercise_date: The shares subject to the option vest as follows: 1/48th of the shares subject to the option vest monthly over four years from June 17, 2021.

Read SEC document
December 16, 2023 Filed Dec 19, 2023 16:05 UTC
Hashim MirChief Scientific Officer
Disposition to issuerStock Option (Right to Buy) · Derivative 83,724 Not disclosed Strike: $9.44 Not disclosed
Disclosure

SEC source: 0000950170-23-071473 · ownership.xml · derivative · entry 5

Hashim Mir · CIK 0001875891 · Chief Scientific Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 127,788

Underlying: Class A Common Stock · 83,724 shares

Expires 2031-07-28

F3 · price: The transactions reported herein reflect a one-time stock option repricing (the "Option Repricing") effective on December 16, 2023 (the "Repricing Date"). Pursuant to the Option Repricing, the exercise price of the repriced options has been amended to reduce the exercise price to $2.84 per share, the closing price of the Issuer's Common Stock on the Repricing Date. There is no change to the expiration dates or the vesting schedule of the repriced options.

F2 · derivative.exercise_date: The remaining shares subject to the option are fully vested and exercisable as of the Repricing Date.

F5 · derivative.exercise_date: The shares subject to the option vest as follows: 1/48th of the shares subject to the option vest monthly over four years from June 17, 2021.

Read SEC document
December 16, 2023 Filed Dec 19, 2023 16:05 UTC
Hashim MirChief Scientific Officer
GrantStock Option (Right to Buy) · Derivative 73,150 Not disclosed Strike: $2.84 Not disclosed
Disclosure

SEC source: 0000950170-23-071473 · ownership.xml · derivative · entry 4

Hashim Mir · CIK 0001875891 · Chief Scientific Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 73,150

Underlying: Class A Common Stock · 73,150 shares

Expires 2032-03-21

F3 · price: The transactions reported herein reflect a one-time stock option repricing (the "Option Repricing") effective on December 16, 2023 (the "Repricing Date"). Pursuant to the Option Repricing, the exercise price of the repriced options has been amended to reduce the exercise price to $2.84 per share, the closing price of the Issuer's Common Stock on the Repricing Date. There is no change to the expiration dates or the vesting schedule of the repriced options.

F4 · derivative.exercise_date: The shares subject to the option vest as follows: 1/48th of the shares subject to the option vest monthly over four years from March 22, 2022.

Read SEC document
December 16, 2023 Filed Dec 19, 2023 16:05 UTC
Hashim MirChief Scientific Officer
Disposition to issuerStock Option (Right to Buy) · Derivative 73,150 Not disclosed Strike: $13.21 Not disclosed
Disclosure

SEC source: 0000950170-23-071473 · ownership.xml · derivative · entry 3

Hashim Mir · CIK 0001875891 · Chief Scientific Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 52,250

Underlying: Class A Common Stock · 73,150 shares

Expires 2032-03-21

F3 · price: The transactions reported herein reflect a one-time stock option repricing (the "Option Repricing") effective on December 16, 2023 (the "Repricing Date"). Pursuant to the Option Repricing, the exercise price of the repriced options has been amended to reduce the exercise price to $2.84 per share, the closing price of the Issuer's Common Stock on the Repricing Date. There is no change to the expiration dates or the vesting schedule of the repriced options.

F2 · derivative.exercise_date: The remaining shares subject to the option are fully vested and exercisable as of the Repricing Date.

F4 · derivative.exercise_date: The shares subject to the option vest as follows: 1/48th of the shares subject to the option vest monthly over four years from March 22, 2022.

F2 · balance_after: The remaining shares subject to the option are fully vested and exercisable as of the Repricing Date.

Read SEC document
December 16, 2023 Filed Dec 19, 2023 16:05 UTC
Hashim MirChief Scientific Officer
GrantStock Option (Right to Buy) · Derivative 171,500 Not disclosed Strike: $2.84 Not disclosed
Disclosure

SEC source: 0000950170-23-071473 · ownership.xml · derivative · entry 2

Hashim Mir · CIK 0001875891 · Chief Scientific Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 171,500

Underlying: Class A Common Stock · 171,500 shares

Expires 2033-03-26

F3 · price: The transactions reported herein reflect a one-time stock option repricing (the "Option Repricing") effective on December 16, 2023 (the "Repricing Date"). Pursuant to the Option Repricing, the exercise price of the repriced options has been amended to reduce the exercise price to $2.84 per share, the closing price of the Issuer's Common Stock on the Repricing Date. There is no change to the expiration dates or the vesting schedule of the repriced options.

F1 · derivative.exercise_date: The shares subject to the option vest as follows: 1/48th of the shares subject to the option vest monthly over four years from March 27, 2023.

Read SEC document
December 16, 2023 Filed Dec 19, 2023 16:05 UTC
Hashim MirChief Scientific Officer
Disposition to issuerStock Option (Right to Buy) · Derivative 171,500 Not disclosed Strike: $5.44 Not disclosed
Disclosure

SEC source: 0000950170-23-071473 · ownership.xml · derivative · entry 1

Hashim Mir · CIK 0001875891 · Chief Scientific Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 34,300

Underlying: Class A Common Stock · 171,500 shares

Expires 2033-03-26

F3 · price: The transactions reported herein reflect a one-time stock option repricing (the "Option Repricing") effective on December 16, 2023 (the "Repricing Date"). Pursuant to the Option Repricing, the exercise price of the repriced options has been amended to reduce the exercise price to $2.84 per share, the closing price of the Issuer's Common Stock on the Repricing Date. There is no change to the expiration dates or the vesting schedule of the repriced options.

F1 · derivative.exercise_date: The shares subject to the option vest as follows: 1/48th of the shares subject to the option vest monthly over four years from March 27, 2023.

F2 · derivative.exercise_date: The remaining shares subject to the option are fully vested and exercisable as of the Repricing Date.

F2 · balance_after: The remaining shares subject to the option are fully vested and exercisable as of the Repricing Date.

Read SEC document
December 16, 2023 Filed Dec 19, 2023 21:05 UTC
Imran TalatDirector · Chief Executive Officer
GrantStock Option (Right to Buy) · Derivative 31,252 Not disclosed Strike: $2.84 Not disclosed
Disclosure

SEC source: 0000950170-23-071472 · ownership.xml · derivative · entry 8

Imran Talat · CIK 0001869579 · Director · Chief Executive Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 31,252

Underlying: Class A Common Stock · 31,252 shares

Expires 2031-07-28

F3 · price: The transactions reported herein reflect a one-time stock option repricing (the "Option Repricing") effective on December 16, 2023 (the "Repricing Date"). Pursuant to the Option Repricing, the exercise price of the repriced options has been amended to reduce the exercise price to $2.84 per share, the closing price of the Issuer's Common Stock on the Repricing Date. There is no change to the expiration dates or the vesting schedule of the repriced options.

F6 · derivative.exercise_date: The shares subject to the option vest as follows: 1/48th of the shares subject to the option vest monthly over four years from June 17, 2021.

Read SEC document
December 16, 2023 Filed Dec 19, 2023 21:05 UTC
Imran TalatDirector · Chief Executive Officer
Disposition to issuerStock Option (Right to Buy) · Derivative 31,252 Not disclosed Strike: $9.44 Not disclosed
Disclosure

SEC source: 0000950170-23-071472 · ownership.xml · derivative · entry 7

Imran Talat · CIK 0001869579 · Director · Chief Executive Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 47,699

Underlying: Class A Common Stock · 31,252 shares

Expires 2031-07-28

F3 · price: The transactions reported herein reflect a one-time stock option repricing (the "Option Repricing") effective on December 16, 2023 (the "Repricing Date"). Pursuant to the Option Repricing, the exercise price of the repriced options has been amended to reduce the exercise price to $2.84 per share, the closing price of the Issuer's Common Stock on the Repricing Date. There is no change to the expiration dates or the vesting schedule of the repriced options.

F2 · derivative.exercise_date: The remaining shares subject to the option are fully vested and exercisable as of the Repricing Date.

F6 · derivative.exercise_date: The shares subject to the option vest as follows: 1/48th of the shares subject to the option vest monthly over four years from June 17, 2021.

Read SEC document
December 16, 2023 Filed Dec 19, 2023 21:05 UTC
Imran TalatDirector · Chief Executive Officer
Grant271875 · Derivative 271,875 Not disclosed Strike: $2.84 Not disclosed
Disclosure

SEC source: 0000950170-23-071472 · ownership.xml · derivative · entry 6

Imran Talat · CIK 0001869579 · Director · Chief Executive Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 271,875

Underlying: Class A Common Stock · 271,875 shares

Expires 2031-09-08

F3 · price: The transactions reported herein reflect a one-time stock option repricing (the "Option Repricing") effective on December 16, 2023 (the "Repricing Date"). Pursuant to the Option Repricing, the exercise price of the repriced options has been amended to reduce the exercise price to $2.84 per share, the closing price of the Issuer's Common Stock on the Repricing Date. There is no change to the expiration dates or the vesting schedule of the repriced options.

F5 · derivative.exercise_date: The shares subject to the option vest as follows: 25% of the shares subject to the option vests on June 14, 2022; and 1/48th of the shares subject to the option vest monthly over the remaining three years.

Read SEC document
December 16, 2023 Filed Dec 19, 2023 21:05 UTC
Imran TalatDirector · Chief Executive Officer
Disposition to issuerStock Option (Right to Buy) · Derivative 271,875 Not disclosed Strike: $19.56 Not disclosed
Disclosure

SEC source: 0000950170-23-071472 · ownership.xml · derivative · entry 5

Imran Talat · CIK 0001869579 · Director · Chief Executive Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 453,125

Underlying: Class A Common Stock · 271,875 shares

Expires 2031-09-08

F3 · price: The transactions reported herein reflect a one-time stock option repricing (the "Option Repricing") effective on December 16, 2023 (the "Repricing Date"). Pursuant to the Option Repricing, the exercise price of the repriced options has been amended to reduce the exercise price to $2.84 per share, the closing price of the Issuer's Common Stock on the Repricing Date. There is no change to the expiration dates or the vesting schedule of the repriced options.

F2 · derivative.exercise_date: The remaining shares subject to the option are fully vested and exercisable as of the Repricing Date.

F5 · derivative.exercise_date: The shares subject to the option vest as follows: 25% of the shares subject to the option vests on June 14, 2022; and 1/48th of the shares subject to the option vest monthly over the remaining three years.

Read SEC document
December 16, 2023 Filed Dec 19, 2023 21:05 UTC
Imran TalatDirector · Chief Executive Officer
GrantStock Option (Right to Buy) · Derivative 153,650 Not disclosed Strike: $2.84 Not disclosed
Disclosure

SEC source: 0000950170-23-071472 · ownership.xml · derivative · entry 4

Imran Talat · CIK 0001869579 · Director · Chief Executive Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 153,650

Underlying: Class A Common Stock · 153,650 shares

Expires 2032-03-21

F3 · price: The transactions reported herein reflect a one-time stock option repricing (the "Option Repricing") effective on December 16, 2023 (the "Repricing Date"). Pursuant to the Option Repricing, the exercise price of the repriced options has been amended to reduce the exercise price to $2.84 per share, the closing price of the Issuer's Common Stock on the Repricing Date. There is no change to the expiration dates or the vesting schedule of the repriced options.

F4 · derivative.exercise_date: The shares subject to the option vest as follows: 1/48th of the shares subject to the option vest monthly over four years from March 22, 2022.

Read SEC document
December 16, 2023 Filed Dec 19, 2023 21:05 UTC
Imran TalatDirector · Chief Executive Officer
Disposition to issuerStock Option (Right to Buy) · Derivative 153,650 Not disclosed Strike: $13.21 Not disclosed
Disclosure

SEC source: 0000950170-23-071472 · ownership.xml · derivative · entry 3

Imran Talat · CIK 0001869579 · Director · Chief Executive Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 109,750

Underlying: Class A Common Stock · 153,650 shares

Expires 2032-03-21

F3 · price: The transactions reported herein reflect a one-time stock option repricing (the "Option Repricing") effective on December 16, 2023 (the "Repricing Date"). Pursuant to the Option Repricing, the exercise price of the repriced options has been amended to reduce the exercise price to $2.84 per share, the closing price of the Issuer's Common Stock on the Repricing Date. There is no change to the expiration dates or the vesting schedule of the repriced options.

F2 · derivative.exercise_date: The remaining shares subject to the option are fully vested and exercisable as of the Repricing Date.

F4 · derivative.exercise_date: The shares subject to the option vest as follows: 1/48th of the shares subject to the option vest monthly over four years from March 22, 2022.

F2 · balance_after: The remaining shares subject to the option are fully vested and exercisable as of the Repricing Date.

Read SEC document
December 16, 2023 Filed Dec 19, 2023 21:05 UTC
Imran TalatDirector · Chief Executive Officer
GrantStock Option (Right to Buy) · Derivative 479,667 Not disclosed Strike: $2.84 Not disclosed
Disclosure

SEC source: 0000950170-23-071472 · ownership.xml · derivative · entry 2

Imran Talat · CIK 0001869579 · Director · Chief Executive Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 479,667

Underlying: Class A Common Stock · 479,667 shares

Expires 2033-03-26

F3 · price: The transactions reported herein reflect a one-time stock option repricing (the "Option Repricing") effective on December 16, 2023 (the "Repricing Date"). Pursuant to the Option Repricing, the exercise price of the repriced options has been amended to reduce the exercise price to $2.84 per share, the closing price of the Issuer's Common Stock on the Repricing Date. There is no change to the expiration dates or the vesting schedule of the repriced options.

F1 · derivative.exercise_date: The shares subject to the option vest as follows: 1/48th of the shares subject to the option vest monthly over four years from March 27, 2023.

Read SEC document

Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.